Discovery Life Sciences provides biospecimens and ancillary services to researchers focused on oncology, hematology and immunology research. In 2013, Discovery Life Sciences expanded services to include neurology, endocrinology and pulmonology. Discovery Life Sciences provides primary tissues and cells matched with the clinical information scientists need to better validate their research so new drugs can reach the patient bedside more quickly. Most projects are prospective in nature; Discovery Life Sciences collects and processes specimens that meet each researcher’s specific criteria for patient selection and sample preparation. Discovery Life Sciences also continues to expand its ability to source normal biospecimens to support general immunology research.

Marshall Schreeder, Jr.
Executive VP, Corp. Dev.

Luke Doiron
Executive VP, Bus. Dev/Marketing

Jay Scherer
Sr. VP, Blood Products & Services

Will Taylor
VP, Finance and Accounting

Erika Hailes
Director, Quality & Regulator

Carolyn Dodson
Director, Human Resources

All resident associate companies on the HudsonAlpha campus are independently owned and operated.